Mitsubishi UFJ Trust & Banking’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-92,731
Closed -$22.8M 1208
2022
Q3
$22.8M Buy
92,731
+511
+0.6% +$138K 0.06% 323
2022
Q2
$22.8M Sell
92,220
-72,080
-44% -$19.5M 0.06% 342
2022
Q1
$54.4M Sell
164,300
-1,461
-0.9% -$450K 0.12% 183
2021
Q4
$59.5M Sell
165,761
-7,487
-4% -$2.53M 0.12% 186
2021
Q3
$56.4M Sell
173,248
-4,112
-2% -$1.39M 0.12% 189
2021
Q2
$55.4M Sell
177,360
-15,603
-8% -$4.79M 0.12% 204
2021
Q1
$61.5M Sell
192,963
-6,896
-3% -$2.21M 0.14% 188
2020
Q4
$64.8M Sell
199,859
-7,190
-3% -$1.99M 0.13% 193
2020
Q3
$57.4M Sell
207,049
-5,978
-3% -$1.72M 0.13% 189
2020
Q2
$51.5M Sell
213,027
-2,980
-1% -$598K 0.12% 195
2020
Q1
$31.4M Sell
216,007
-109
-0.1% -$18.1K 0.09% 245
2019
Q4
$36.9M Buy
216,116
+4,248
+2% +$788K 0.09% 261
2019
Q3
$37.7M Buy
211,868
+22,189
+12% +$4.8M 0.1% 247
2019
Q2
$49.4M Buy
189,679
+42,838
+29% +$11.4M 0.17% 129
2019
Q1
$41.9M Buy
146,841
+897
+0.6% +$298K 0.15% 144
2018
Q4
$47.4M Sell
145,944
-11,422
-7% -$3.97M 0.2% 115
2018
Q3
$70.8M Sell
157,366
-142,026
-47% -$56M 0.25% 91
2018
Q2
$122M Buy
299,392
+662
+0.2% +$240K 0.21% 108
2018
Q1
$86.9M Sell
298,730
-11,280
-4% -$2.86M 0.15% 148
2017
Q4
$58.1M Sell
310,010
-11,430
-4% -$2.13M 0.1% 225
2017
Q3
$54.2M Sell
321,440
-8,460
-3% -$1.28M 0.1% 231
2017
Q2
$47.3M Sell
329,900
-3,440
-1% -$462K 0.09% 258
2017
Q1
$41.7M Buy
333,340
+80,100
+32% +$9.28M 0.08% 278
2016
Q4
$28.5M Sell
253,240
-38,320
-13% -$4.44M 0.06% 364
2016
Q3
$37.5M Buy
291,560
+1,170
+0.4% +$140K 0.08% 297
2016
Q2
$31.7M Sell
290,390
-11,600
-4% -$1.15M 0.07% 325
2016
Q1
$28.6M Buy
301,990
+82,280
+37% +$6.95M 0.06% 340
2015
Q4
$19.8M Buy
+219,710
New +$18.6M 0.05% 448

Other funds holding ABMD

Mitsubishi UFJ Trust & Banking's ABMD Position: Q4 2022 in Review

Mitsubishi UFJ Trust & Banking sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 92,731 shares — an estimated $22.8M sold.

Mitsubishi UFJ Trust & Banking first reported a position in ABMD in Q4 2015 and held it in 28 quarters. The position peaked at $122M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Mitsubishi UFJ Trust & Banking reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 92,731 Abiomed Inc shares in Q4 2022, an estimated $22.8M.
  • Mitsubishi UFJ Trust & Banking first reported a position in Abiomed Inc in Q4 2015 and held it in 28 quarters.
  • Mitsubishi UFJ Trust & Banking's Abiomed Inc position peaked at $122M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q4 2022, filed 10 Feb 2023.